POLYPOIDAL CHOROIDAL VASCULOPATHY
Clinical trials for POLYPOIDAL CHOROIDAL VASCULOPATHY explained in plain language.
Never miss a new study
Get alerted when new POLYPOIDAL CHOROIDAL VASCULOPATHY trials appear
Sign up with your email to follow new studies for POLYPOIDAL CHOROIDAL VASCULOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New eye drug regimen could mean fewer shots for PCV patients
Disease control Recruiting nowThis study tests a higher dose of the eye medication aflibercept (8 mg) given on a personalized schedule for people with a specific type of wet macular degeneration called polypoidal choroidal vasculopathy (PCV). The goal is to see if this approach can safely extend the time betw…
Matched conditions: POLYPOIDAL CHOROIDAL VASCULOPATHY
Phase: PHASE3 • Sponsor: Yeungnam University College of Medicine • Aim: Disease control
Last updated May 26, 2026 11:03 UTC
-
New eye drug aims to save sight in rare vision disorder
Disease control Recruiting nowThis study tests an eye injection called faricimab in 120 Caucasian adults with polypoidal choroidal vasculopathy (PCV), a condition that causes vision loss. The goal is to see if the drug improves eyesight and how long the effects last. Participants receive injections based on t…
Matched conditions: POLYPOIDAL CHOROIDAL VASCULOPATHY
Phase: PHASE4 • Sponsor: Association for Innovation and Biomedical Research on Light and Image • Aim: Disease control
Last updated May 26, 2026 10:51 UTC